the role of primary health care to follow up women with
play

The Role of Primary Health Care to Follow up Women With Cervical - PowerPoint PPT Presentation

ROP25 Federal University of Rio Grande do Sul Faculty of Medicine Post-Graduate Program of Epidemiology The Role of Primary Health Care to Follow up Women With Cervical Cancer Precursor Lesions Wilhelms D.M., Bozzetti M.C. , Flores R. Objective


  1. ROP25 Federal University of Rio Grande do Sul Faculty of Medicine Post-Graduate Program of Epidemiology The Role of Primary Health Care to Follow up Women With Cervical Cancer Precursor Lesions Wilhelms D.M., Bozzetti M.C. , Flores R. Objective To evaluate the screening program developed in Primary Care Services (PCS), especially regarding the follow-up of positive cases identified during screening. Methods • Historical cohort • Women attending PCS, in Southern Brazil. • Inclusion Criteria: all women who presented precursor lesions of cervical cancer in the PAP smear, between 2001 and 2007 were enrolled and followed up to 2011. • Previous cervical screening history, diagnosis/treatment, and follow-up were evaluated.

  2. ROP25 Methods • Fase 1 – Analysis of all PAPs collected between 2001 and 2007 to select those showing precursor lesions; • Focus on screening by age, specimen adequacy (satisfactory vs unsatisfactory) and percent of abnormal exams. • Fase 2 – Screening analysis; – Diagnostic and treatment analysis; – Follow-up (to the year 2011) of women with precursor lesions Inclusion criterium – women with the following cytological results: ASC-H, HSIL or Carcinoma (Squamous/Adeno), identified between 2001 and 2007. Exclusion criterium - women with the following cytological results:HSIL or Carcinoma (Squamous/Adeno), before the year 2001.

  3. ROP25 46018 cytologic exams • Study Sample 2001 to 2007 ASC-US LSIL HSIL ASC-H AGUS Carcinoma (Ca) 1626 (63%) 775 (30%) 119 (4.6%) 11 (0.43%) 41 (1.6%) 10 (0.38%) Studied population = 134 women 78 CIN II 36 CIN III 58% 27% 11 ASC-H 9 Ca 114 (85%) 8% 7% • Results: Previous screening (n/%) ASC-H CIN II CIN III Carcinoma NO 3(5%) 23(45%) 17(33%) 8(16%) YES 8(10%) 55(66%) 19(23%) 1(1%) ! Referred to gynecologist 10(91%) 74(95%) 33(92%) 9(100%) ! Attended Appointment 9(90%) 72(97%) 33(100%) 8(89%) ! Histology performed 9(100%) 65(90%) 32(97%) 8(100%) ! Diagnosis confirmation 4(44%) 48(74%) 31(97%) 8(100%)

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend